[{"orgOrder":0,"company":"Indena","sponsor":"Indena","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"ITALY","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Artichoke Extract","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Indena","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Indena"},{"orgOrder":0,"company":"Indena","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"ITALY","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Grape Seed Extract","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Undisclosed"},{"orgOrder":0,"company":"Indena","sponsor":"Istituto Superiore di Sanit\u00e0 | Sintesi Research Srl","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"ITALY","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Meriva","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Indena \/ Istituto Superiore di Sanit\u00e0 | Sintesi Research Srl","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Istituto Superiore di Sanit\u00e0 | Sintesi Research Srl"},{"orgOrder":0,"company":"Indena","sponsor":"Thorne HealthTech","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Quercetin Phytosome","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Indena","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Indena \/ Indena","highestDevelopmentStatusID":"1","companyTruncated":"Indena \/ Indena"}]

Find Clinical Drug Pipeline Developments & Deals by Indena

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : Grape Seed Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Prehypertension.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          July 29, 2025

                          Lead Product(s) : Grape Seed Extract

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : Quercetin Phytosome is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Aging.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          March 25, 2022

                          Lead Product(s) : Quercetin Phytosome

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Undisclosed

                          Recipient : Thorne HealthTech

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Lead Product(s) : Meriva

                          Therapeutic Area : Neurology

                          Study Phase : Undisclosed

                          Sponsor : Istituto Superiore di Sanità | Sintesi Research Srl

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Meriva is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognitive Dysfunction.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          January 12, 2021

                          Lead Product(s) : Meriva

                          Therapeutic Area : Neurology

                          Highest Development Status : Undisclosed

                          Sponsor : Istituto Superiore di Sanità | Sintesi Research Srl

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : Artichoke Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Insulin Resistance.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          November 05, 2020

                          Lead Product(s) : Artichoke Extract

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Recipient : Azienda di Servizi alla Persona di Pavia

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank